CSL Limited (CSL)

Index: ASX 100
0.20%
A$0.27
A$133.08
07:37 22/09/17
A$133.08
07:37 22/09/17
DAILY VARIATION
0.20%
A$0.27
VOLUME
366,800
DATA
52 Week High
A$143.33
52 Week Low
A$92.10
Shares Issued
452.48m
Market Cap
A$60,216.12m
RiskGrade
n/a
Beta
0.41
MENU

CSL Limited Overview

CSL is a global biopharmaceutical company that develops, construct and promotes products to treat and prevent medical conditions. The group operating in 27 countries worldwide produce various blood plasma, cell reagents, antivenom and other vaccines through their protein based biotherapies.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.6% 1.2%
Div Cover 2.3 2.2
Op Mrgn 27.4% 24.1%
ROCE 31.6%
Latest F'cast
P/E 70.3 3,604.9
PEG 8.0 3.2
Pr/Revenue 13.6 7.3
Pr/Book 17.6
Latest F'cast
Revenue 5.9% 0.0%
PBT 1.6% n/a
EPS 8.8% 0.0%
DPS 3.8% 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield

Forecast

slide to see more
Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
2016-06-30 8,028.55 1,933.33 325.93c 4,018.1 55.6 72% 166.51c 1.3%
2017-06-30 8,198.27 1,974.35 363.28c 3,604.9 314.5 11% 161.73c 1.2%
2018-06-30 9,433.94 2,516.18 442.68c 2,974.4 136.1 22% 195.38c 1.5%

Regulatory News

No results found

Latest Sharecast News

No results found

Newspaper Links

No results found